FANGZHOU JIANKE(06086),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06086 FANGZHOU JIANKE

Market Closed 04-02 16:08:21

1.310

-0.030

-2.24%

High1.350	Low1.310	Vol413.00K
Open1.340	D1 Closing1.340	Amplitude2.99%
Mkt Cap1.81B	Tradable Cap1.81B	Total Shares1.39B
T/O550.01K	T/O Rate0.03%	Tradable Shares1.39B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06086","market":"HK","secType":"STK","nameCN":"FANGZHOU JIANKE","latestPrice":1.31,"timestamp":1775117301007,"preClose":1.34,"halted":0,"volume":413000,"delay":0,"changeRate":-0.022388059701492557,"floatShares":1385000000,"shares":1385000000,"eps":0.010096773489669874,"marketStatus":"Market Closed","change":-0.03,"latestTime":"04-02 16:08:21","open":1.34,"high":1.35,"low":1.31,"amount":550005,"amplitude":0.029851,"askPrice":1.34,"askSize":7500,"bidPrice":1.31,"bidSize":106500,"shortable":3,"etf":0,"ttmEps":0.010096773489669874,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":7,"adr":0,"listingDate":1720454400000,"exchange":"SEHK","adjPreClose":1.34,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":0.2886093641052642,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06086","defaultTab":"news","newsList":[{"id":"1189001967","title":"Fangzhou Inc. Maintains 1.39 Billion Outstanding Shares, Confirms Adequate Public Float for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1189001967","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189001967?lang=en_us&edition=fundamental","pubTime":"2026-04-02 16:44","pubTimestamp":1775119467,"startTime":"0","endTime":"0","summary":"Fangzhou Inc. (HKEX: 06086) has filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, confirming that both authorised and issued share capital remained unchanged during the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622546810","title":"Fangzhou Appoints CEO; Shares Jump 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622546810","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622546810?lang=en_us&edition=fundamental","pubTime":"2026-03-27 14:14","pubTimestamp":1774592084,"startTime":"0","endTime":"0","summary":"Fangzhou  has appointed Wang Haijiao as chief executive officer with effect from Thursday, according to a same-day Hong Kong bourse filing.Shares of the online chronic disease management platform gained over 6% in Friday afternoon trade.Wang has nearly 20 years of experience in healthcare investment and management, most recently serving as deputy general manager and executive partner at GTJA Investment Group, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06086","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120657623","title":"Fangzhou Announces Updated Board and Committee Composition","url":"https://stock-news.laohu8.com/highlight/detail?id=1120657623","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120657623?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:23","pubTimestamp":1774524195,"startTime":"0","endTime":"0","summary":"Hong Kong, 26 March 2026 — Fangzhou Inc. disclosed an updated list of directors and detailed the latest composition of its three board committees. The board now comprises eight members: Executive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104686676","title":"FANGZHOU JIANKE Appoints Wang Haijiao as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=1104686676","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104686676?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:20","pubTimestamp":1774524027,"startTime":"0","endTime":"0","summary":"FANGZHOU JIANKE (06086) has announced the appointment of Mr. Wang Haijiao as the company's Chief Executive Officer and an Executive Director, effective March 26, 2026.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622974851","title":"Fangzhou files list of directors to the Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2622974851","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622974851?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:08","pubTimestamp":1774523319,"startTime":"0","endTime":"0","summary":"Fangzhou filed a list of directors naming Zhou Feng, Zou Yuming, and Wang Haijiao as executive directors.David McKee Hand was listed as chairman of the board and a non-executive director, and Xie Fangmin was listed as a non-executive director.Independent non-executive directors were Wang Haizhong, Kang Wei, and Zhu Xiaolu.Zhu Xiaolu was named chairman of the audit committee, with Wang Haizhong and Kang Wei as members.Kang Wei was named chairlady of the remuneration committee, and Zhu Xiaolu was named chairman of the nomination committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fangzhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exch","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDLbxZD6z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1247","06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622085194","title":"Fangzhou names WANG Haijiao CEO and executive director; base salary rises to RMB 2.4 million per year","url":"https://stock-news.laohu8.com/highlight/detail?id=2622085194","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622085194?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:07","pubTimestamp":1774523251,"startTime":"0","endTime":"0","summary":"Fangzhou appointed Wang Haijiao as chief executive officer and executive director, effective March 26, 2026.Wang Haijiao previously served as deputy general manager, investment committee member, and executive partner at GTJA Investment Group after joining in 2014.Wang Haijiao is also a director of Guangzhou LBP Medicine Science & Technology .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fangzhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDLbVz9DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601211","BK0188","BK0276","BK1247","BK0201","BK0028","BK0012","BK0183","BK0184","06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622519138","title":"Fangzhou Inc - Appoints Wang Haijiao as CEO and Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2622519138","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622519138?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:07","pubTimestamp":1774523240,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1247","06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621797145","title":"Fangzhou (SEHK:6086) Profit Swing To C¥12m Revives Bullish Growth Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2621797145","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621797145?lang=en_us&edition=fundamental","pubTime":"2026-03-22 05:05","pubTimestamp":1774127103,"startTime":"0","endTime":"0","summary":"Fangzhou (SEHK:6086) has opened FY 2025 with first half revenue of C¥1.49b and basic EPS of C¥0.009, setting a very different tone from the heavy losses seen a year ago. The company has seen revenue move from C¥1.32b in 1H 2024 to C¥1.49b in 1H 2025, while EPS has shifted from a loss of C¥1.27 to a small profit. This has put fresh attention on how durable this early profit recovery might be. With that backdrop, the latest numbers invite a closer look at how far margins have really come and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5021000-choice2-main-header/1585187320441","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5021000-choice2-main-header/1585187320441"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6086/fangzhou-shares/news/fangzhou-sehk6086-profit-swing-to-c12m-revives-bullish-growt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6086/fangzhou-shares/news/fangzhou-sehk6086-profit-swing-to-c12m-revives-bullish-growt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BLSG","06086","BK4112","BLSX","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139310467","title":"Undervalued Industry Leader? FANGZHOU JIANKE (06086) Achieves Full Profitability, \"AI+Chronic Disease Services\" Drives Valuation Model Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=1139310467","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139310467?lang=en_us&edition=fundamental","pubTime":"2026-03-20 14:35","pubTimestamp":1773988528,"startTime":"0","endTime":"0","summary":"As Artificial Intelligence empowers the healthcare industry with unprecedented depth, AI health applications are no longer confined to one-off online consultations. They are evolving towards...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1247","06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121625055","title":"Stock Track | FANGZHOU JIANKE Soars 5.71% Intraday on Strong 2025 Results and AI Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1121625055","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121625055?lang=en_us&edition=fundamental","pubTime":"2026-03-20 09:44","pubTimestamp":1773971099,"startTime":"0","endTime":"0","summary":"FANGZHOU JIANKE's stock price soared 5.71% during intraday trading on Friday, following the release of the company's 2025 annual results which showed a significant turnaround to profitability and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620224162","title":"BRIEF-Fangzhou Posts FY Net Profit Of Rmb12.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620224162","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620224162?lang=en_us&edition=fundamental","pubTime":"2026-03-20 00:03","pubTimestamp":1773936211,"startTime":"0","endTime":"0","summary":"BRIEF-Fangzhou Posts FY Net Profit Of Rmb12.0 MillionMarch 19 (Reuters) - Fangzhou Inc 6086.HK:FY  NET PROFIT OF RMB12.0 MILLIONFY REVENUE RMB3.53 BILLIONFurther company coverage: 6086.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nFWN4070TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620822406","title":"Press Release: Fangzhou Reports Robust 2025 Financial Results, Boosted by AI Chronic Care Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2620822406","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620822406?lang=en_us&edition=fundamental","pubTime":"2026-03-19 23:35","pubTimestamp":1773934500,"startTime":"0","endTime":"0","summary":"SHANGHAI, March 19, 2026  -- Fangzhou Inc.  , a leading provider of AI-driven Internet healthcare solutions, reported its 2025 annual results, posting strong revenue growth and achieving full-year profitability, as its AI-enabled chronic disease management model continues to scale. Total revenue rose 30.2% year on year to RMB 3.53 billion in 2025, driven by steady growth in its consumer-facing businesses, including comprehensive medical services and online retail pharmacy services, which collectively grew by approximately 30%. The Company also recorded net profit of RMB 12 million, exceeding market expectations and marking a turnaround from a net loss in 2024. Adjusted net profit was up 19%, reaching RMB 20.4 million. This strong performance reflects continued momentum in Fangzhou's core businesses and validates the effectiveness of the strong doctor--patient relationship model that underpins its chronic care platform.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","BK4587","AIYY","BK4588","AI","BK4023","BK4528","BK4585","BK1247","BK4551","06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176107985","title":"FANGZHOU JIANKE (06086) Reports 2025 Results: Revenue Surges 30.2% YoY, Net Profit at RMB 11.832 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1176107985","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176107985?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:50","pubTimestamp":1773931824,"startTime":"0","endTime":"0","summary":"FANGZHOU JIANKE (06086) has announced its financial results for 2025, revealing a significant 30.2% year-on-year increase in revenue to RMB 3.53 billion. The company achieved a net profit of RMB...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141885888","title":"FANGZHOU JIANKE (06086) 2025 Results: Revenue Up 30.20% to RMB3.53 Billion, Swings to RMB12.00 Million Net Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1141885888","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141885888?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:40","pubTimestamp":1773931247,"startTime":"0","endTime":"0","summary":"Fangzhou Inc. (stock name FANGZHOU JIANKE, 06086) released its audited results for the year ended 31 December 2025. Revenue and Earnings   • Revenue jumped 30.20% year-on-year to RMB3.53 billion,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620213272","title":"Fangzhou FY2025 revenue rose 30.2% to RMB3.53 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2620213272","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620213272?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:38","pubTimestamp":1773931132,"startTime":"0","endTime":"0","summary":"Fangzhou published an annual results announcement for the year ended Dec. 31, 2025, reporting revenue of RMB3.53 billion, up 30.2%.Profit and total comprehensive income was RMB11.83 million, while adjusted net profit  was RMB20.4 million.Gross profit rose 8.4% to RMB559.44 million, and gross margin was 15.9%.Selling and distribution expenses increased 12.8% to RMB401.24 million, while administrative expenses fell 83.8% to RMB147.29 million due mainly to lower share-based compensation.Business updates included the launch of the “XingShi” large language model and average MAU of 13.7 million, up 35%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fangzhou Inc. published the original content used to generate this news brief via IIS, the Is","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL8wTvjr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1247","06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620376221","title":"Fangzhou Inc - FY Revenue RMB3.53 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2620376221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620376221?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:38","pubTimestamp":1773931114,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nFWN4070TG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06086","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620221371","title":"Fangzhou Inc - FY  Net Profit of RMB12.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2620221371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620221371?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:38","pubTimestamp":1773931114,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nFWN4070TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06086","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192488194","title":"FANGZHOU JIANKE (06086.HK) Sets 19 March 2026 Board Meeting to Review FY 2025 Results and Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1192488194","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192488194?lang=en_us&edition=fundamental","pubTime":"2026-03-09 17:23","pubTimestamp":1773048188,"startTime":"0","endTime":"0","summary":"Fangzhou Inc. (stock code: 06086), also known as FANGZHOU JIANKE, has scheduled a board meeting for 19 March 2026. The agenda includes: • Reviewing and approving the consolidated financial results...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191852005","title":"Fangzhou Inc. (06086) Publishes February 2026 Monthly Return, Issued Shares Increase by 45.18 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1191852005","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191852005?lang=en_us&edition=fundamental","pubTime":"2026-03-02 16:47","pubTimestamp":1772441231,"startTime":"0","endTime":"0","summary":"Fangzhou Inc. disclosed its monthly return for February 2026, reporting that the authorized share capital remained at 2.50 billion ordinary shares, par value USD 0.00002 each, totaling USD 50,000....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614890748","title":"Fangzhou Inc. and Youcare Pharmaceutical Group Form Strategic AI Chronic Care Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2614890748","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614890748?lang=en_us&edition=fundamental","pubTime":"2026-02-28 15:12","pubTimestamp":1772262760,"startTime":"0","endTime":"0","summary":"Fangzhou Inc. has signed a strategic collaboration agreement with Youcare Pharmaceutical Group to advance AI-driven chronic disease services in China. The partners will co-develop digitally enabled chronic care management systems combining Youcare’s pharmaceutical expertise with Fangzhou’s AI healthcare platform, and expand full-lifecycle health management services across areas including cardiovascular, infectious and endocrine diseases.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260228:nNDL4g7y0L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","BK1247","LU0314104364.USD","SG9999014021.USD","BK4588","LU2210149790.SGD","BK4585","LU2210150020.SGD","SG9999014013.SGD","NDAQ","SG9999014039.USD","SG9999014005.SGD","688658","06086","IE00BGHQF748.EUR","BK4112","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://Jianke.com","stockEarnings":[{"period":"1week","weight":-0.0076},{"period":"1month","weight":-0.3641},{"period":"3month","weight":-0.4126},{"period":"6month","weight":-0.6836},{"period":"1year","weight":-0.6836},{"period":"ytd","weight":-0.4178}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Fangzhou Inc is an investment holding company principally engaged in the provision of online chronic disease management services. The Company operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.","exchange":"SEHK","name":"FANGZHOU JIANKE","nameEN":"FANGZHOU JIANKE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FANGZHOU JIANKE(06086),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest FANGZHOU JIANKE(06086) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"FANGZHOU JIANKE,06086,FANGZHOU JIANKE股票,FANGZHOU JIANKE股票老虎,FANGZHOU JIANKE股票老虎国际,FANGZHOU JIANKE行情,FANGZHOU JIANKE股票行情,FANGZHOU JIANKE股价,FANGZHOU JIANKE股市,FANGZHOU JIANKE股票价格,FANGZHOU JIANKE股票交易,FANGZHOU JIANKE股票购买,FANGZHOU JIANKE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FANGZHOU JIANKE(06086),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest FANGZHOU JIANKE(06086) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}